Nearly 20% of patients with type 2 diabetes do not benefit from exercise

the ONA take:

According to a new study published in the Journal of Clinical Endocrinology & Metabolism, one in five people with type 2 diabetes mellitus do not achieve any improvement in blood sugar control when they participate in a supervised exercise regimen.

For the study, researchers analyzed data from clinical studies that investigated the use of exercise regimens in patients with type 2 diabetes. They also looked at animal and genetic studies that did the same. Results showed that about 15 to 20% of patients with type 2 diabetes did not experience improvement in blood sugar control, insulin sensitivity, or muscle mitochondrial density.

The animal and genetic studies suggest that the resistance to exercise is genetic and can be passed from one generation to the next.

The U.S. Centers for Disease Control and Prevention estimates that about 40% of American will develop type 2 diabetes in their lifetime. Because obesity and lack of exercise are associated with the disease, exercise is often recommended to patients with diabetes to help manage the disease.

This study shows that while most people benefit from exercise, nearly 20% of patients with type 2 diabetes do not as a result of their DNA.

Exercise halves breast cancer risk
One in five people with type 2 diabetes mellitus do not achieve any improvement in blood sugar control.
As many as one in five people with Type 2 diabetes do not see any improvement in blood sugar management when they engage in a supervised exercise regimen, according to a new scientific review published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
READ FULL ARTICLE From Medical News Today
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs